No source study found
Story checked
Experts have found an unexpected side-effect of weight-loss drugs | BBC Science Focus Magazine (opens in a new tab)
sciencefocus.com · 2026-10-02
Short answer
No source study foundNo confirmed study match.
We couldn’t confidently identify the source study behind this story. This leaves its claims unverified — not disproven.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
Experts have found an unexpected side-effect of weight-loss drugs | BBC Science Focus Magazine
sciencefocus.com · 2026-10-02
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
We couldn't find the study behind this story.
We couldn't match the article's details against the peer-reviewed literature closely enough. The study may be paywalled, very new, or not indexed.
Open claim evidenceSearch result
No source study found.
We couldn't match the article's details against the peer-reviewed literature closely enough. The study may be paywalled, very new, or not indexed.
Source layer
The paper behind the story
The source record for this check.
The research anchor for the report.
- Also referencedpresented as the new finding
https://eadv.org/wp-content/uploads/2026/09/EADV_2026_Bruno_GLP1_Press_Release_01_10.pdf
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 7Not checkedWeight-loss medications may make nails more likely to fall off, according to new research.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 7Not checkedIn a study of almost 2,000 people that has not yet been peer-reviewed, researchers found GLP-1 users were more than four times more likely to experience nail detachment than non-users.View evidenceHide evidence
As statedmore than four times more likely
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 7Not checkedAfter accounting for age, sex, country and medical background, nail detachment was still at least twice as common among GLP-1 users.View evidenceHide evidence
As statedat least twice as common
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 7Not checkedOverall, 66% of people taking GLP-1 drugs reported at least one nail problem, compared with 53% of non-users, and nail discoloration affected 46% of GLP-1 users versus 17% of non-users.View evidenceHide evidence
As stated66% vs 53%; 46% vs 17%
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 7Not checkedThe researchers caution that GLP-1 drugs may not directly cause the nail changes and that rapid weight loss, reduced food intake, and nutrient deficiencies could be an indirect explanation.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 7Not checkedA separate study of the same group found GLP-1 users were more than twice as likely to develop hair loss, and many also had scalp symptoms such as itching, redness or flaky skin.View evidenceHide evidence
As statedmore than twice as likely
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 7 of 7Not checkedThe article says the hair loss could reflect telogen effluvium from rapid weight loss, and that hair and nail changes after weight loss usually recover, though toenails may take longer to regrow.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Crossref, Europe PMC · 15 candidate papers
GLP-1R agonism in breast cancer: a metabolic-oncogenic switch?
Metabolism Open · 2026 · PubMed
Review for "Prevalence and Predictors of Residual Gastric Content in Patients with Type 2 Diabetes on GLP-1 Receptor Agonists: A Prospective Observational Study"
2026 · Crossref
The cutaneous mirror: leveraging drug-induced skin phenotypes as early visual risk signals for systemic toxicity, a comprehensive review.
2026 · Europe PMC
Glucagon-like peptide-1 receptor agonists and aesthetic surgery: perioperative safety, timing, durability and body composition.
Frontiers in Endocrinology · 2026 · PubMed
Review for "Prevalence and Predictors of Residual Gastric Content in Patients with Type 2 Diabetes on GLP-1 Receptor Agonists: A Prospective Observational Study"
2025 · Crossref